Clinical trial

Acute Bronchodilator Response of a Single Dose of Atrovent or Berotec on Top of…

NCT00274066 · Boehringer Ingelheim, Industry · Completed

Key facts

NCT number NCT00274066
Title Acute Bronchodilator Response of a Single Dose of Atrovent or Berotec on Top of Pharmacodynamic Steady State of Spiriva
Official title The Acute Bronchodilator Effects of a Single Dose (2 Puffs) of the Shortacting Anticholinergic Ipratropium Bromide (40μg) and the Short-acting Beta-adrenergic Fenoterol (200μg) in Comparison to Placebo on Top of Pharmacodynamic Steady State of Once Daily Tiotropium (18μg) Inhalation Capsule in…
Lead sponsor Boehringer Ingelheim, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Pulmonary Disease, Chronic Obstructive
Intervention type Drug
Interventions Tiotropium + placebo, Tiotropium + ipratropium, Tiotropium + fenoterol
Enrollment 65
Start date Oct 1, 2002
Primary completion Sep 1, 2003
Completion Sep 1, 2003
First posted Jan 10, 2006
Last update posted Nov 1, 2013
Countries Netherlands

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies